Personalized Medicine – News and Features

By studying mutations in a gene called neurexin-1, which is highly associated with both schizophrenia and autism, researchers have discovered that different types of mutations in the gene require different treatments.

Stanford Medicine researchers have created a liquid biopsy test capable of detecting cancers, molecular mechanisms of resistance to treatment and tissue injury.

Conducting a meta-analysis of genetic databases involving nearly 2 million people including nearly half a million patients with osteoarthritis, researchers found 962 genetic markers associated with the condition.

Researchers used mutational analysis to identify gene mutations that may drive carcinogenesis in colorectal tumors with high tumor mutation burden.

A longitudinal atlas of neuroblastoma, a common and deadly childhood cancer, could uncover the precise molecular mechanisms underlying why and how certain treatments eventually become ineffective.

A new study reveals how inherited genetic variants influence cancer biology. Analyzing data from over 1,000 patients across 10 cancer types, the study shows that these germline mutations affect protein activity.

A study challenges the "digital dementia" hypothesis, showing that digital technology use is linked to improved cognitive aging outcomes. The study found a 58% lower risk of cognitive impairment in adults who engaged with technology.

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment.

Discover how microbial biotechnology could reduce suffering and support global health goals, as experts call for awareness and greater investment in innovation.

A repurposed anti-cancer drug, Cilengitide, was found to reduce kidney scarring and slow disease progression in preclinical models, suggesting a possible precision medicine approach for high-risk patients.